Risek treats benign gastric ulcer, esophageal reflux, acidity, duodenal ulcer, Helicobacter pylori, ulcers associated with non-steroidal anti-inflammatory drugs, erosive esophagitis, and pathological hypersecretory conditions where
Risek is a proton pump inhibitor by irreversibly blocking the hydrogen peroxide/potassium enzyme system, thus preventing the secretion of gastric acid.